Saudi Food and Drug Authority - Regulatory authority for pharmaceuticals and medical devices in Saudi Arabia
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| Cabozantinib BOS | Natco Pharma Limited | Tablet | Jan 1, 2024 | Generic |
| Daglozin | Sudair Pharma Company | Film-coated tablet | Jan 1, 2024 | Generic |
| Cabozantinib BOS | Natco Pharma Limited | Tablet | Jan 1, 2024 | Generic |
| Teralas | Pharmacare Premium Ltd | Film-coated tablet | Jan 1, 2024 | Generic |
| CEVENFACTA | sanofi S.R.L | Powder and solvent for solution for injection | Jan 1, 2024 | Biological |
| CEVENFACTA | sanofi S.R.L | Powder and solvent for solution for injection | Jan 1, 2024 | Biological |
| Tepkinly | VETTER PHARMA | concentrate for solution for injection | Jan 1, 2024 | Biological |
| Sildenafil | Novitium Pharma LLC | Powder for oral suspension | Jan 1, 2024 | Generic |
| Pomalidomide BOS | Natco Pharma Limited | Capsule | Jan 1, 2024 | Generic |
| Cabozantinib BOS | Natco Pharma Limited | Film-coated tablet | Jan 1, 2024 | Generic |
| Pomalidomide BOS | Natco Pharma Limited | Capsule | Jan 1, 2024 | Generic |
| Locain | Unicare Pharma | Spray | Jan 1, 2024 | Generic |
| Pomalidomide BOS | Natco Pharma Limited | Capsule | Jan 1, 2024 | Generic |
| Cuprtin | Hetero Labs Limited Unit – III | Capsule, hard | Jan 1, 2024 | Generic |
| Ensutine | DR. REDDY | Solution for injection | Jan 1, 2024 | Generic |
| CEVENFACTA | sanofi S.R.L | Powder and solvent for solution for injection | Jan 1, 2024 | Biological |
| Pomalidomide BOS | Natco Pharma Limited | Capsule | Jan 1, 2024 | Generic |
| Fibrosta | Hikma Farmaceutica | Concentrate for solution for infusion | Jan 1, 2024 | Generic |
| Sotyktu | Patheon Inc. | Film-coated tablet | Jan 1, 2024 | NCE |
| Nyvepria | HOSPIRA ZAGREB D.O.O. | Solution for injection | Jan 1, 2024 | Biological |
